Case report Panuveitis: a case of suspected ocular tuberculosis
Abstract
A 32-year-old incarcerated man was evaluated for decreased vision in both eyes at a tertiary care facility. He presented with uveitis and the initial work up indicated that tuberculosis was the most likely etiology. This report will discuss the frequency, presentation, diagnostic procedures and yield, and treatment of ocular tuberculosis.Downloads
References
WHO. Tuberculosis. Access to the WHO global TB database 2017. http://www.who.int/tb/publications/global_report/en/.
Donahue HC. Ophthalmologic experience in a tuberculosis sanatorium. Am J Ophthalmol 1967;64(4):742-748.
Bouza E, Merino P, Munoz P, et al. Ocular tuberculosis. A prospective study in a general hospital. Medicine (Baltimore) 1997;76(1):53-61.
Henderly DE, Genstler AJ, Smith RE, et al. Changing patterns of uveitis. Am J Ophthalmol 1987;103(2):131-136.
Garip A, Diedrichs-Mohring M, Thurau SR, et al. Uveitis in a patient treated with Bacille-Calmette-Guerin: possible antigenic mimicry of mycobacterial and retinal antigens. Ophthalmology 2009;116(12):2452-2457. doi:10.1016/j.ophtha.2009.05.021
Gupta V, Gupta A, Rao NA. Intraocular tuberculosis—an update. Surv Ophthalmol 2007;52(6):561-587. doi:https://doi.org/10.1016/j.survophthal.2007.08.015
Gupta A, Bansal R, Gupta V, et al. Ocular signs predictive of tubercular uveitis. Am J Ophthalmol 2010;149(4):562-570. doi:https://doi.org/10.1016/j.ajo.2009.11.020
Arora SK, Gupta V, Gupta A, et al. Diagnostic efficacy of polymerase chain reaction in granulomatous uveitis. Tuber Lung Dis 1999;79(4):229-233. doi:https://doi.org/10.1054/tuld.1999.0210
Kharel Sitaula R, Janani MK, Madhavan HN, et al. Outcome of polymerase chain reaction (PCR) analysis in 100 suspected cases of infectious uveitis. J Ophthalmic Inflamm Infect 2018;8(1):2. doi:10.1186/s12348-017-0144-1
Bhagya S, Lalitha P, Kumar AL,et al. Polymerase chain reaction and its correlation with clinical features and treatment response in tubercular uveitis. Ocul Immunol Inflamm June 2017:1-8. doi:10.1080/09273948.2017.1287925
Kataria P, Kumar A, Bansal R, et al. devR PCR for the diagnosis of intraocular tuberculosis. Ocul Immunol Inflamm 2015;23(1). doi:10.3109/09273948.2014.981550
Kee AR, Gonzalez-Lopez JJ, Al-Hity A, et al. Anti-tubercular therapy for intraocular tuberculosis: A systematic review and meta-analysis. Surv Ophthalmol 2016;61(5):628-653. doi:10.1016/j.survophthal.2016.03.001
Elimination DoT. Tuberculosis - Treatment. Centers for Disease Control and Prevention. https://www.cdc.gov/tb/topic/treatment/tbdisease.htm. Published 2016. Accessed April 14, 2018.
Lou SM, Montgomery PA, Larkin KL, et al. Diagnosis and treatment for ocular tuberculosis among uveitis specialists: The international perspective. Ocul Immunol Inflamm 2015;23(1). doi:10.3109/09273948.2014.994784
Ang M, Hedayatfar A, Wong W, et al. Duration of anti-tubercular therapy in uveitis associated with latent tuberculosis: A case-control study. Br J Ophthalmol 2012;96(3):332-336. doi:10.1136/bjophthalmol-2011-300209
Hamade IH, Tabbara KF. Complications of presumed ocular tuberculosis. Acta Ophthalmol 2010;88(8):905-909. doi:10.1111/j.1755-3768.2009.01579.x
Gupta V, Gupta A, Rao NA. Intraocular Tuberculosis-An Update. Surv Ophthalmol 2007;52(6):561-587. doi:10.1016/j.survophthal.2007.08.015
Dooley DP, Carpenter JL, Rademacher S. Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis 1997;25(4):872-887. http://dx.doi.org/10.1086/515543.
Fonollosa A, Valsero S, Artaraz J, et al. Dexamethasone intravitreal implants in the management of tubercular multifocal serpiginoid choroiditis. J Ophthalmic Inflamm Infect 2016;6(1):31. doi:10.1186/s12348-016-0101-4
Agarwal A, Handa S, Aggarwal K, et al. The role of dexamethasone implant in the management of tubercular uveitis. Ocul Immunol Inflamm November 2017:1-9. doi:10.1080/09273948.2017.1400074
Ang M, Chee SP. Controversies in ocular tuberculosis. Br J Ophthalmol. 2017;101(1):6-9. doi:10.1136/bjophthalmol-2016-309531
